Scancell Holdings (SCLP) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Aug 2021 07:00 AM
RNS
Modi-1 Phase I/II CTA approved by MHRA
17 Aug 2021 07:00 AM
RNS
Scancell selects PharmaJet's Needle-free Systems
30 Jul 2021 09:52 AM
RNS
Director Dealing
29 Jul 2021 07:00 AM
RNS
COVIDITY Phase 1 trial application in SA approved
28 Jul 2021 05:00 PM
RNS
Lindy Durrant appointed CEO of Scancell
22 Jun 2021 07:00 AM
RNS
COVIDITY trial planned in South Africa and UK
15 Jun 2021 07:00 AM
RNS
Appointment of Joint Broker
08 Jun 2021 04:41 PM
RNS
Second Price Monitoring Extn
08 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
07 Jun 2021 08:49 AM
RNS
Director Dealing
30 Apr 2021 10:48 AM
RNS
Director Dealing
10 Mar 2021 09:58 AM
RNS
Holding(s) in Company
02 Mar 2021 04:40 PM
RNS
Second Price Monitoring Extn
02 Mar 2021 04:35 PM
RNS
Price Monitoring Extension
19 Feb 2021 03:00 PM
RNS
Director Dealing
19 Feb 2021 07:00 AM
RNS
Director Dealing
17 Feb 2021 02:04 PM
RNS
Director Dealing
16 Feb 2021 03:00 PM
RNS
BLOCK LISTING SIX MONTHLY RETURN
15 Feb 2021 03:36 PM
RNS
Statement regarding share price movement
15 Feb 2021 11:05 AM
RNS
Second Price Monitoring Extn
15 Feb 2021 11:00 AM
RNS
Price Monitoring Extension
15 Feb 2021 09:05 AM
RNS
Second Price Monitoring Extn
15 Feb 2021 09:00 AM
RNS
Price Monitoring Extension
03 Feb 2021 07:00 AM
RNS
Update on SCIB2 clinical development partnership
29 Jan 2021 07:00 AM
RNS
Interim Results for the 6 months ended 31 Oct 2020
30 Dec 2020 02:00 PM
RNS
Price Monitoring Extension
30 Dec 2020 11:05 AM
RNS
Second Price Monitoring Extn
30 Dec 2020 11:00 AM
RNS
Price Monitoring Extension
18 Dec 2020 04:41 PM
RNS
Second Price Monitoring Extn
18 Dec 2020 04:35 PM
RNS
Price Monitoring Extension
18 Dec 2020 02:05 PM
RNS
Second Price Monitoring Extn
18 Dec 2020 02:00 PM
RNS
Price Monitoring Extension
18 Dec 2020 07:00 AM
RNS
COVID-19 vaccine candidate selected
15 Dec 2020 03:45 PM
RNS
Director Dealing
14 Dec 2020 01:03 PM
RNS
Director Dealing
25 Nov 2020 11:26 AM
RNS
Director Dealing
17 Nov 2020 02:34 PM
RNS
Results of Annual General Meeting
17 Nov 2020 12:00 PM
RNS
Appointment of CMO and Medical Director
13 Nov 2020 12:36 PM
RNS
Director Dealing
10 Nov 2020 02:44 PM
RNS
Director Dealing
09 Nov 2020 02:06 PM
RNS
Second Price Monitoring Extn
09 Nov 2020 02:01 PM
RNS
Price Monitoring Extension
06 Nov 2020 11:49 AM
RNS
Holding(s) in Company
05 Nov 2020 10:51 AM
RNS
Result of Adjourned General Meeting
03 Nov 2020 08:33 AM
RNS
Holding(s) in Company
02 Nov 2020 05:00 PM
RNS
Convertible Loan Notes & Total Voting Rights
29 Oct 2020 10:15 AM
RNS
Result of Open Offer and Adjournment of GM
27 Oct 2020 04:41 PM
RNS
Second Price Monitoring Extn
27 Oct 2020 04:36 PM
RNS
Price Monitoring Extension
26 Oct 2020 10:10 AM
RNS
Conversion of Convertible Loan Notes

Scancell Holdings PLC is a biopharmaceutical company that develops vaccines and other therapies to treat cancer and infectious diseases. Scancell's research focuses on the human immune system and how to use it to develop new treatments. Scancell uses four technology platforms to develop its products: ImmunoBody, Moditope, GlyMab and AvidiMab.

Scancell was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham.

Scancell Holdings PLC is listed on the London Stock Exchange (LSE) as SCLP.

Scancell share price listed at 8p in 2010.

UK 100

Latest directors dealings